Targeting vaccinia to solid tumors with local hyperthermia
/in Hyperthermia, International Publications, Newcastle Disease VirusT-cell triggering by CD3- and CD28-binding molecules linked to a human virus-modified tumor cell vaccine
/in International Publications, Newcastle Disease VirusTherapeutic effect of autologous dendritic cell vaccine on patients with chronic hepatitis B: a clinical study
/in Chronic Virus Hepatitis, International PublicationsTumour-dendritic hybrid cell vaccination for the treatment of patients with malignant melanoma: immunological effects and clinical results
/in International Publications, Malignant MelanomaImmunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells
/in Dendritic Cells, International Publications, Malignant Pleural MesotheliomaThe large scale generation of dendritic cells for the immunization of patients with non-small cell lung cancer (NSCLC)
/in Dendritic Cells, International Publications, NSCLCProcessing and presentation of exogenous HLA class I peptides by dendritic cells from human immunodeficiency virus type 1-infected persons
/in HIV/AIDS, International PublicationsSelective gene transfer in vitro to tumor cells via recombinant Newcastle disease virus
/in International Publications, Newcastle Disease VirusA pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late-stage lung carcinoma
/in International Publications, NSCLC
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer